Skip to: Content
Skip to: Site Navigation
Skip to: Search
FRIDAY, NOVEMBER 27, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter


0

New Drug Battles Liver Cancer

Nexavar, already approved for kidney cancer, shows promise in liver patients

Share

(Newser) – An impressive clinical trial has produced what could be the first effective drug treatment for liver cancer, the New York Times reports. Nexavar, which blocks both the blood supply to the tumor and proteins that spur tumor growth, extended the lives of patients in the trial by almost three months, or 44%

"We did not have anything for these patients," said one of the principal investigators  in the trial. "Now we have an effective drug that prolongs survival." The drug, also known as sorafenib, is already approved to treat kidney cancer, so it can be prescribed "off label" to liver patients. Liver cancer is one of the most common, and deadliest, forms of the disease.

US NEWS LIVERCANCER 2 MW
US NEWS LIVERCANCER 2 MW   (KRT Photos)
US NEWS LIVERCANCER 1 MW
US NEWS LIVERCANCER 1 MW   (KRT Photos)
« Prev« Prev | Next »Next » Slideshow
OFF THE GRID
11.24.09
Murdoch and Microsoft: The Mice Are Trying to Roar
11.23.09
Books Are Bad for You
0 comments
VIEWING:
 
LEAVE A
COMMENT Comment Policy
Facebook ConnectPost this comment to Facebook?

After connecting you will have the option to post your comment on your Facebook profile.

 

Related Newser Stories

162 Stories

 Pain-Relieving 
 Morphine May 
 Spread Cancer 

But drug to counter harmful effect exists

Nov 23, 09 7:44 AM CST
(Newser) - Morphine, a painkiller often prescribed to ease cancer patients' suffering, may in fact encourage the spread of the disease. A new study suggests that the opiate strengthens blood vessels that deliver oxygen and nutrients to tumors, as well as makes it easier for cancers to invade new tissues and spread,... More »

MORE ABOUT:
cancer • cancer treatment • morphine • opiates

Now Panel Urges Delay
in Pap Test

Docs' group advises later start, every 2 years for cervical cancer test

Nov 20, 09 7:46 AM CST
(Newser) - The screening cutbacks continue. Just days after the government announced more conservative guidelines for mammograms, a major medical body says women should begin having Pap smears for cervical cancer later and less frequently. The new guidelines from the American College of Obstetricians and Gynecologists say women don't need to be... More »

MORE ABOUT:
cancer • health • cervical cancer • gynecology • Pap smear • American College of Obstetricians and Gynecologists • older women • Pap smear guidelines

3 US Genetics Researchers Win Medicine Nobel

Work in replication of chromosomes may aid cancer treatment

Oct 5, 09 5:37 AM CDT
(Newser) - Three American scientists won the Nobel Prize for Medicine today for their work on the replication of chromosomes, which has implications for cancer, aging, and stem cell research. The laureates focused on a string of DNA at the end of chromosomes, called telomeres, and discovered an enzyme that allows dividing... More »

MORE ABOUT:
cancer • medicine • stem cell research • genetics • DNA • Nobel Prize

162 Stories


Business  •  Science & Health  •  US 
TwitterFollow @Newser on Twitter

 
cancer • medicine • health • drugs • Nexavar • liver cancer • treatment • cancer treatment • tumor • sorafenib

from our news partners

PopEater.com